Investigating the Performance of a New Adhesive Strip
- Conditions
- Ileostomy - Stoma
- Interventions
- Other: New adhesive strip
- Registration Number
- NCT03423134
- Lead Sponsor
- Coloplast A/S
- Brief Summary
This study investigates the performance of a new adhesive
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6
- Have given written informed consent
- Be at least 18 years of age and have full legal capacity
- Have had a stoma for more than one year
- Have intact skin on the area used in the evaluation
- Has a stoma with a diameter up to (≤) 35 mm
- Have a peristomal area accessible for application of patches/adhesive strips (assessed by investigating scientist)
- Currently receiving or have within the past 2 month received radio- and/or chemotherapy
- Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
- Are pregnant or breastfeeding
- Having dermatological problems in the peristomal- or abdominal area (assessed by investigating scientist)
- Actively participating in other interventional clinical investigations or have previously participated in this investigation.
5.1. Exception: Participation in other Coloplast in-house clinical investigations are accepted under the circumstances of otherwise complying with the Inclusion and exclusion criteria of this protocol (CP265)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Test of new adhesive strip New adhesive strip A new adhesive strip will be tested in this investigation
- Primary Outcome Measures
Name Time Method trans epidermal water loss 24 hours The trans epidermal water loss is a measure for the skins barrier function. There is always a loss of water from the skin due to evaporation. When the skin barrier is damaged the evaporation of water increases. Thus, trans epidermal water loss can be used to assess skin damage
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Coloplast A/S
🇩🇰Humlebæk, Denmark